A decreased abundance of Firmicutes, a decreased Firmicutes to Bacteroidetes ratio (F/B), and a lower expression of IL-6 concentration after overexpression of hepatic miRNA-29a (anti-inflammatory) may be relevant to obesity and MASLD in C57BL/6 mice [85]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.